1. Home
  2. USNA vs ASMB Comparison

USNA vs ASMB Comparison

Compare USNA & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo USANA Health Sciences Inc.

USNA

USANA Health Sciences Inc.

HOLD

Current Price

$22.71

Market Cap

397.1M

Sector

Health Care

ML Signal

HOLD

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$25.72

Market Cap

442.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USNA
ASMB
Founded
1992
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
397.1M
442.9M
IPO Year
1996
2010

Fundamental Metrics

Financial Performance
Metric
USNA
ASMB
Price
$22.71
$25.72
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$44.20
AVG Volume (30 Days)
97.6K
245.6K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
91.78
EPS
0.41
N/A
Revenue
$1,060,902,000.00
N/A
Revenue This Year
$3.90
N/A
Revenue Next Year
$6.21
$638.39
P/E Ratio
$54.70
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.60
$16.90
52 Week High
$38.32
$39.71

Technical Indicators

Market Signals
Indicator
USNA
ASMB
Relative Strength Index (RSI) 65.03 44.98
Support Level $18.71 $21.80
Resistance Level $22.64 $30.47
Average True Range (ATR) 1.01 1.42
MACD 0.06 -0.10
Stochastic Oscillator 85.97 27.00

Price Performance

Historical Comparison
USNA
ASMB

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

Share on Social Networks: